首页> 美国卫生研究院文献>The British Journal of Ophthalmology >A randomised clinical trial comparing 2 econazole and 5 natamycin for the treatment of fungal keratitis
【2h】

A randomised clinical trial comparing 2 econazole and 5 natamycin for the treatment of fungal keratitis

机译:一项比较2%益康唑和5%那他霉素治疗真菌性角膜炎的随机临床试验

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

>Aim: To compare 2% econazole and 5% natamycin in the management of fungal keratitis.>Methods: A randomised clinical trial was performed using 2% econazole or 5% natamycin as the two treatment arms on patients presenting with culture positive fungal keratitis to the cornea service at Aravind Eye Care System, Madurai, India.>Results: 116 patients were recruited, and 112 continued in the study. There were no significant differences between the two arms at baseline or for success (defined as a healed or healing ulcer) at final visit (p = 0.79).>Conclusions: 2% Econazole appears to be as effective as 5% natamycin for the management of fungal keratitis.
机译:>目标:比较2%益康唑和5%那他霉素在真菌性角膜炎治疗中的作用。>方法:使用2%益康唑或5%那他霉素作为临床试验进行了一项随机临床试验在印度马杜赖(Madurai)的Aravind眼保健系统中,对出现角膜培养阳性真菌性角膜炎的患者进行了两个治疗。两组在基线时或最终访视时成功与否(定义为已治愈的溃疡或愈合的溃疡)之间均无显着差异(p = 0.79)。>结论: 2%的益康唑与5%那他霉素用于治疗真菌性角膜炎。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号